Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 351 - 375 of 644 in total

EGT-201

EGT-201 is an adeno-associated viral vector serotype 9 (AAV9) vector-based gene therapy consisting of the alpha-N-acetyglucosaminidase (NAGLU) transgene. Developed by Esteve Pharmaceuticals, it is being investigated for Sanfilippo syndrome type B.
Investigational

Rezatomidine

Rezatomidine has been used in trials studying the treatment of Fibromyalgia, Cystitis, Interstitial, Irritable Bowel Syndrome, and Diabetic Neuropathy, Painful.
Investigational
Matched Description: … in trials studying the treatment of Fibromyalgia, Cystitis, Interstitial, Irritable Bowel Syndrome, and …

Chitosan low molecular weight (20-200 mpa.s)

Experimental
Matched Synonyms: … Poliglusam low molecular weight (20-200 mpa.s) …
Matched Name: … Chitosan low molecular weight (20-200 mpa.s) …

Gildeuretinol

Investigational

Quinoline Yellow WS

Experimental
Matched Synonyms: … D and C Yellow No. 10 …

Ezeprogind

Investigational

P-2045 Re-188

Investigational

Icotinib

Icotinib is a potent and specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) Icotinib was approved in China by the SFDA in June, 2011 and in January 2014, Beta Pharma, Inc. was given a “May Proceed” from the US FDA to conduct a Phase I study for the...
Experimental
Investigational
Matched Description: … Icotinib is a potent and specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor ( ... TKI) Icotinib was approved in China by the SFDA in June, 2011 and in January 2014, Beta Pharma, Inc. …
Matched Categories: … Antineoplastic and Immunomodulating Agents …

Fimaporfin

Investigational
Matched Synonyms: … or 17,18)-dihydro-21h,23h-porphine-5,10-diyl)bisbenzenesulfonic acid, mixture of three isomers a, b and …

3,20-Pregnanedione

Experimental

CIGB 2020 Vaccine

CIGB 2020 is a vaccine candidate administered nasally and sublingually, working to strengthen immunity in the areas administered. The vaccine was developed and tested by the Center for Genetic Engineering and Biotechnology (CIGB), in Havana Cuba. As of July, 2020, a Randomized control clinical trial (RPCEC00000306) is underway to evaluate...
Investigational
Matched Description: … The vaccine was developed and tested by the Center for Genetic Engineering and Biotechnology (CIGB), ... CIGB 2020 is a vaccine candidate administered nasally and sublingually, working to strengthen immunity …

Namilumab

Namilumab has been used in trials studying the treatment of Plaque Psoriasis and Rheumatoid Arthritis.
Investigational
Matched Description: … Namilumab has been used in trials studying the treatment of Plaque Psoriasis and Rheumatoid Arthritis …
Matched Categories: … Amino Acids, Peptides, and Proteins …

Fletikumab

Fletikumab is under investigation in clinical trial NCT01038674 (Safety and Tolerability of Anti-IL-20 in Subjects With Rheumatoid Arthritis).
Investigational
Matched Synonyms: … Anti-IL-20 …
Matched Description: … Fletikumab is under investigation in clinical trial NCT01038674 (Safety and Tolerability of Anti-IL-20 …
Matched Categories: … Amino Acids, Peptides, and Proteins …

CAM-GM201

Investigational
Matched Synonyms: … rAAV2/1 Hex alpha and beta ... Recombinant adeno-associated viral vector serotype 2/1 encoding human beta-hexosaminidase alpha and beta …

Thallium Tl-201

Thallium Tl-201 is under investigation in clinical trial NCT02697760 (The CZT Dynamic Myocardial Perfusion Imaging).
Investigational

Zamtocabtagene autoleucel

Investigational

PBCAR20A

Investigational

Polifeprosan 20

Polifeprosan 20 is under investigation in clinical trial NCT00003878 (Carmustine Implants in Treating Patients With Brain Metastases).
Investigational
Matched Synonyms: … Polifeprosan 20 …
Matched Name: … Polifeprosan 20 …
Matched Description: … Polifeprosan 20 is under investigation in clinical trial NCT00003878 (Carmustine Implants in Treating …

BN-201

Investigational

TN-201

TN-201 is a gene therapy comprising a native AAV9 capsid with a genomic cassette containing a cardiomyocyte-specific promoter and the wild-type human MYBPC3 gene.
Investigational
Matched Synonyms: … Native AAV9 capsid with a genomic cassette containing a cardiomyocyte-specific promoter and the wild-type …
Matched Description: … comprising a native AAV9 capsid with a genomic cassette containing a cardiomyocyte-specific promoter and …

Rubitecan

Investigational
Matched Synonyms: … 9-nitro-20(S)-camptothecin ... 9-nitro-20-(S)-camptothecin …
Matched Iupac: … nitro-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20 …

T-2000

T2000 has been used in trials studying the treatment of Myoclonus and Essential Tremor.
Investigational
Matched Description: … T2000 has been used in trials studying the treatment of Myoclonus and Essential Tremor. …

IO-202

IO-202 is a first-in-class antibody targeting the Leukocyte Immunoglobulin-Like Receptor subfamily B (LILRB) member 4 (LILRB4). It is being investigated in cancers.
Investigational

EVT 201

EVT 201 is a novel partial positive allosteric modulator of the GABAA receptor complex which is being developed as a treatment for insomnia. It is being developed by Evotec Inc.
Investigational

DDP-200

DDP200 is developed by Dynogen for the treatment of non-incontinent form of overactive bladder (OAB) with particular focus on both male and female patients with urinary frequency, urinary urgency and nocturia.
Investigational
Matched Description: … female patients with urinary frequency, urinary urgency and nocturia. ... the treatment of non-incontinent form of overactive bladder (OAB) with particular focus on both male and …
Displaying drugs 351 - 375 of 644 in total